Schroeder Mark S

SEC source: 0000920148-26-000124 · form4.xml · nonDerivative · entry 4

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,677.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0000920148-26-000124 · form4.xml · nonDerivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,145.1426

F3 · kind: Shares acquired on March 26, 2026, pursuant to a performance award granted on May 5, 2023, relating to performance during the three-year period ended December 31, 2025.

SEC source: 0000920148-26-000124 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,177.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0000920148-26-000124 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,777.1426

F1 · kind: Shares acquired on March 26, 2026, pursuant to a performance award granted on February 7, 2023, relating to performance during the three-year period ended December 31, 2025.

SEC source: 0000920148-26-000087 · form4.xml · derivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,358

Underlying: Common Stock · 806 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2026.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0000920148-26-000087 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,473.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0000920148-26-000087 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,732.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0000920148-26-000029 · form4.xml · nonDerivative · entry 6

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,926.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0000920148-26-000029 · form4.xml · nonDerivative · entry 5

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,979.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0000920148-26-000029 · form4.xml · derivative · entry 9

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,164

Underlying: Common Stock · 164 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.

F5 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0000920148-26-000029 · form4.xml · derivative · entry 8

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,328

Underlying: Common Stock · 517 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.

F5 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 7, 2024 and are now fully vested.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0000920148-26-000029 · form4.xml · nonDerivative · entry 4

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,145.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0000920148-26-000029 · form4.xml · nonDerivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,981.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0000920148-26-000029 · form4.xml · derivative · entry 7

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,845

Underlying: Common Stock · 743 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0000920148-26-000029 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,464.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0000920148-26-000029 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,703.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0001127602-25-010624 · form4.xml · nonDerivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,960.1426

F3 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

SEC source: 0001127602-25-010624 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 7,595.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-010624 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 9,800.1426

F1 · kind: Shares acquired on March 27, 2025, pursuant to a performance award granted on February 11, 2022, relating to performance during the three-year period ended December 31, 2024.

SEC source: 0001127602-25-007615 · form4.xml · derivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 3,903 shares

Expires 2029-02-11

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.

F3 · derivative.exercise_date: The options vested in three equal annual installments beginning on the date reflected in this column.

SEC source: 0001127602-25-007615 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 4,960.1426

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

SEC source: 0001127602-25-007615 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,299.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

SEC source: 0001127602-25-004536 · form4.xml · derivative · entry 5

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,588

Underlying: Common Stock · 473 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F7 · derivative.exercise_date: The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested.

F7 · derivative.expiration_date: The Restricted Stock Units vested in three equal annual installments beginning on February 11, 2023 and are now fully vested.

F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-004536 · form4.xml · derivative · entry 4

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,061

Underlying: Common Stock · 2,420 shares

Expires not disclosed

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.

F5 · derivative.expiration_date: The Restricted Stock Units vest in three equal annual installments beginning on February 11, 2026.

F6 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-004536 · form4.xml · derivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,300

Underlying: Common Stock · 7,300 shares

Expires 2035-02-10

F3 · security: Employee stock option (right to buy) granted pursuant to the Labcorp Holdings Inc. Amended and Restated 2016 Omnibus Incentive Plan.

F4 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column.

SEC source: 0001127602-25-004536 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,396.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-004536 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,530.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. Common Stock.

SEC source: 0001127602-25-003716 · form4.xml · derivative · entry 9

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,641

Underlying: Common Stock · 164 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.

F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003716 · form4.xml · derivative · entry 8

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,805

Underlying: Common Stock · 517 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F5 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.

F5 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 6

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,057.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 5

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,104.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 4

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,940.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,086.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-25-003716 · form4.xml · derivative · entry 7

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,322

Underlying: Common Stock · 743 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 6, 2025.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,569.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-25-003716 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,779.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Labcorp Holdings Inc. ("LHI") Common Stock.

SEC source: 0001127602-24-012006 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,036.1426

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

SEC source: 0000920148-24-000023 · primary_doc.xml · derivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,065

Underlying: Common Stock · 11,556 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock.

F1 · price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock.

F3 · derivative.exercise_date: As previously reported, in connection with the spin-off ("Spin-Off") of Fortrea Holdings Inc. ("Fortrea") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the "EMA") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024.

F3 · derivative.expiration_date: As previously reported, in connection with the spin-off ("Spin-Off") of Fortrea Holdings Inc. ("Fortrea") by Labcorp, performance awards granted by Labcorp in 2021 for the 3-year performance period through December 31, 2023 (the "2021 PSA") were converted into time-vesting RSUs of Labcorp pursuant to the terms of the Employee Matters Agreement (the "EMA") by and between Labcorp and Fortrea. The 2021 PSA was converted into a number of time-vesting Labcorp RSUs, based on the degree of achievement of the performance criteria subject to the 2021 PSA prior to the Spin-Off and the final adjustment ratio applied to Labcorp equity awards in connection with the Spin-Off, calculated pursuant to the terms of the EMA, which fully vested on March 27, 2024.

F4 · balance_after: This number reflects the aggregate number of RSUs held by the reporting person.

SEC source: 0000920148-24-000023 · primary_doc.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,513.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0000920148-24-000023 · primary_doc.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,592.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit ("RSU") represents the contingent right to receive one share of Laboratory Corporation of America Holdings ("Labcorp") Common Stock.

SEC source: 0001127602-24-009301 · form4.xml · derivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 2,119 shares

Expires 2027-02-06

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · security: Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2016 Omnibus Incentive Plan.

F3 · derivative.exercise_price: Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.

F3 · shares: Represents amounts automatically adjusted based on the final adjustment ratio applied to equity awards in connection with the spin-off of Fortrea Holdings Inc. ("Fortrea") by Laboratory Corporation of America Holdings ("Labcorp"), calculated pursuant to the terms of the Employee Matters Agreement by and between Labcorp and Fortrea.

F4 · derivative.exercise_date: The option vested in three equal annual installments beginning on the date reflected in this column.

SEC source: 0001127602-24-009301 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 5,036.1426

F1 · kind: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

SEC source: 0001127602-24-009301 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 10,084.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001127602-24-004638 · form4.xml · nonDerivative · entry 2

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,965.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-24-004638 · form4.xml · derivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 15,621

Underlying: Common Stock · 472 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F3 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023.

F3 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 11, 2023.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-24-004638 · form4.xml · nonDerivative · entry 1

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,091.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

SEC source: 0001127602-24-003954 · form4.xml · derivative · entry 8

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,093

Underlying: Common Stock · 163 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F7 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.

F7 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-24-003954 · form4.xml · derivative · entry 7

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,256

Underlying: Common Stock · 517 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.

F7 · derivative.exercise_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.

F7 · derivative.expiration_date: The Restricted Stock Units that have vested were part of a grant that vests in three equal annual installments beginning on February 7, 2024.

F4 · balance_after: This number reflects the aggregate number of Restricted Stock Units held by the reporting person.

SEC source: 0001127602-24-003954 · form4.xml · nonDerivative · entry 4

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,619.1426

F2 · kind: Stock withholding to satisfy tax withholding obligations.

SEC source: 0001127602-24-003954 · form4.xml · nonDerivative · entry 3

Schroeder Mark S · CIK 0001793112 · EVP, Pres Diagnostics & COO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,663.1426

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Each Restricted Stock Unit represents the contingent right to receive one share of Laboratory Corporation of America Holdings Common Stock.